FASN and infection: Both orlistat, (broad lipase inhibitor that also blocks FASN)39, and JW480 (a selective neutral cholesteryl ester hydrolase inhibitor)38 substantially reduced virus production (≥1-log) at 24h post infection (Figure 6F), supporting our hypothesis.